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Abstract
Some new 3H-quinazolin-4-one derivatives  were synthesised and screened for anticancer , antiphospholipases , 
antiproteases , and antimetabolic  syndrome  activities . Compound 15d was more potent in reducing the cell
viabilities of HT-29 and SW620 cells lines to 38%, 36.7%, compared to 5-FU which demonstrated cell viabilities of 65.9
and 42.7% respectively. The IC  values of 15d were ∼20 µg/ml. Assessment of apoptotic activity  revealed that 15d
decreased the cell viability by down regulating Bcl2 and BclxL. Moreover, compounds, 8j, 8d/15a/15e, 5b, and 8f
displayed lowered IC  values than oleanolic acid against proinflammatory isoforms of hGV, hG-X, NmPLA  and
AmPLA  . In addition, 8d, 8h, 8j, 15a, 15b, 15e, and 15f showed better anti-α-amylase than quercetin, whereas 8g, 8h,
and 8i showed higher anti-α-glucosidase activity  than allopurinol. Thus, these compounds can be considered as
potential antidiabetic agents. Finally, none of the compounds showed higher antiproteases  or xanthine oxidase 
activities  than the used reference drugs. © 2019, © 2019 The Author(s). Published by Informa UK Limited, trading
as Taylor & Francis Group.
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